This new nonaddictive alternative is the first of its kind that interrupts the pain signal before it reaches the brain.

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

A man who alleges A$AP Rocky fired a handgun at him in 2021 returns to the courthouse Friday for more cross-examination after ...

The most important testimony at the trial of rapper A$AP Rocky got second billing as the defendant’s partner and the mother of their children sat quietly but shined bright like ...

Superstar singer Rihanna has made her first appearance at the trial of her partner, rapper A$AP Rocky. The couple that has ...

Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial (ClinicalTrials.gov Identifier: ...

Rihanna appeared in Los Angeles court earlier today to support ASAP Rocky as he stands trial for felony assault charges ...